{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:22:46Z","timestamp":1792581766873,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To identify optical coherence tomography (OCT) features to predict the course of central serous chorioretinopathy (CSC) with an artificial intelligence\u2013based program.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Multicenter, observational study with a retrospective design. Treatment-na\u00efve patients with acute CSC and chronic CSC were enrolled. Baseline OCTs were examined by an artificial intelligence\u2013developed platform (Discovery OCT Fluid and Biomarker Detector, RetinAI AG, Switzerland). Through this platform, automated retinal layer thicknesses and volumes, including intaretinal and subretinal fluid, and pigment epithelium detachment were measured. Baseline OCT features were compared between acute CSC and chronic CSC patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred and sixty eyes of 144 patients with CSC were enrolled, of which 100 had chronic CSC and 60 acute CSC. Retinal layer analysis of baseline OCT scans showed that the inner nuclear layer, the outer nuclear layer, and the photoreceptor\u2013retinal pigmented epithelium complex were significantly thicker at baseline in eyes with acute CSC in comparison with those with chronic CSC (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Similarly, choriocapillaris and choroidal stroma and retinal thickness (RT) were thicker in acute CSC than chronic CSC eyes (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001). Volume analysis revealed average greater subretinal fluid volumes in the acute CSC group in comparison with chronic CSC (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.041).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Optical coherence tomography features may be helpful to predict the clinical course of CSC. The baseline presence of an increased thickness in the outer retinal layers, choriocapillaris and choroidal stroma, and subretinal fluid volume seems to be associated with acute course of the disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003965","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T18:04:57Z","timestamp":1698343497000},"page":"316-323","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHY"],"prefix":"10.1097","volume":"44","author":[{"given":"Lorenzo","family":"Ferro Desideri","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"},{"name":"Bern Photographic Reading Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Anguita","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"},{"name":"Moorfields Eye Hospital NHS Foundation Trust, London;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieselotte E.","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"},{"name":"Department for Bio-Medical Research, University of Bern, Bern, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena M. A.","family":"Feenstra","sequence":"additional","affiliation":[{"name":"ARTORG Research Center Biomedical Engineering Research, University of Bern, Bern, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Scandella","sequence":"additional","affiliation":[{"name":"ARTORG Research Center Biomedical Engineering Research, University of Bern, Bern, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Sznitman","sequence":"additional","affiliation":[{"name":"ARTORG Research Center Biomedical Engineering Research, University of Bern, Bern, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel J. F.","family":"Boon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands;"},{"name":"\u2020Department of Ophthalmology, Amsterdam University Medical Centers, Amsterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elon H. C.","family":"van Dijk","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Zinkernagel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"},{"name":"Bern Photographic Reading Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"},{"name":"Department for Bio-Medical Research, University of Bern, Bern, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"100865","DOI":"10.1016\/j.preteyeres.2020.100865","article-title":"Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities","volume":"79","author":"Kaye","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00417-016-3417-8","article-title":"Central serous chorioretinopathy in primary hyperaldosteronism","volume":"254","author":"van Dijk","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","article-title":"Acute central serous chorioretinopathy: factors influencing episode duration","volume":"37","author":"Daruich","year":"2017","journal-title":"Retina"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/bjophthalmol-2020-317422","article-title":"Central serous chorioretinopathy imaging biomarkers","volume":"106","author":"Singh","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"649316","DOI":"10.3389\/fphys.2021.649316","article-title":"Predicting central serous chorioretinopathy recurrence using machine learning","volume":"12","author":"Xu","year":"2021","journal-title":"Front Physiol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"242","DOI":"10.21037\/atm-20-1519","article-title":"Predicting subretinal fluid absorption with machine learning in patients with central serous chorioretinopathy","volume":"9","author":"Xu","year":"2021","journal-title":"Ann Transl Med"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"649221","DOI":"10.3389\/fbioe.2021.649221","article-title":"Predicting post-therapeutic visual acuity and OCT images in patients with central serous chorioretinopathy by artificial intelligence","volume":"9","author":"Xu","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1159\/000527345","article-title":"Evaluation of an artificial intelligence-based detector of sub- and intraretinal fluid on a large set of optical coherence tomography volumes in age-related macular degeneration and diabetic macular edema","volume":"245","author":"Habra","year":"2022","journal-title":"Ophthalmologica"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/tvst.10.4.17","article-title":"Automated quantification of pathological fluids in neovascular age-related macular degeneration, and its repeatability using deep learning","volume":"10","author":"Mantel","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"e1522","DOI":"10.1111\/aos.15148","article-title":"Clinical impact of the worldwide shortage of verteporfin (Visudyne\u00ae) on ophthalmic care","volume":"100","author":"Sirks","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.3390\/jcm11164766","article-title":"European prevalence of polypoidal choroidal vasculopathy: a systematic review, meta-analysis, and forecasting study","volume":"11","author":"van Dijk","year":"2022","journal-title":"J Clin Med"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","article-title":"Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy (SPECTRA): a randomized controlled trial","volume":"233","author":"van Rijssen","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R17-20250605","first-page":"2515841420950846","article-title":"Biomarkers for central serous chorioretinopathy","volume":"12","author":"Nkrumah","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"issue":"2","key":"R18-20250605","first-page":"11206721221137153","article-title":"Biomarkers predicting central serous chorioretinopathy episode persistence","volume":"33","author":"Kiraly","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"20446","DOI":"10.1038\/s41598-021-99977-4","article-title":"Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence","volume":"11","author":"Pfau","year":"2021","journal-title":"Sci Rep"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/aos.14901","article-title":"Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data","volume":"100","author":"Subhi","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/IAE.0000000000002092","article-title":"Correlations between changes in photoreceptor layer and other clinical characteristics in central serous chorioretinopathy","volume":"39","author":"Yu","year":"2019","journal-title":"Retina"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IAE.0000000000002445","article-title":"Elongated photoreceptor outer segment length and prognosis of chronic central serous chorioretinopathy","volume":"40","author":"Asano","year":"2020","journal-title":"Retina"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"e0202549","DOI":"10.1371\/journal.pone.0202549","article-title":"Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"13","author":"van Rijssen","year":"2018","journal-title":"PLoS One"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"824239","DOI":"10.3389\/fmed.2021.824239","article-title":"Changes in the foveal outer nuclear layer of central serous chorioretinopathy patients over the disease course and their response to photodynamic therapy","volume":"8","author":"Deng","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajo.2004.08.037","article-title":"The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy","volume":"139","author":"Piccolino","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/jcm8091271","article-title":"Optical coherence tomography parameters as predictors of treatment response to eplerenone in central serous chorioretinopathy","volume":"8","author":"Borrelli","year":"2019","journal-title":"J Clin Med"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/eye.2016.209","article-title":"Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy","volume":"30","author":"Ambiya","year":"2016","journal-title":"Eye (Lond)."},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2415-14-145","article-title":"Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy","volume":"14","author":"Hamzah","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central serous chorioretinopathy in younger and older adults","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:04:43Z","timestamp":1749143083000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003965","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}